PURPOSE: To determine the reproducibility of proton MR spectroscopy ((1) H-MRS) for assessing vertebral bone marrow adiposity at 3 Tesla (T); to evaluate variation of marrow adiposity at different vertebral levels; and to demonstrate the feasibility of using (1) H-MRS at 3T for evaluating marrow adiposity in subjects with low bone density. MATERIALS AND METHODS: Single voxel MRS was acquired at vertebral body L1 to L4 at 3T in 51 postmenopausal females including healthy controls (n = 13) and patients with osteoporosis/osteopenia (n = 38). Marrow fat contents were compared between vertebral levels and between groups using analysis of variance (ANOVA). Six subjects were scanned twice to evaluate technique reproducibility. RESULTS: The average coefficient of variation of vertebral marrow fat content quantification was 1.7%. Marrow fat content significantly increased from L1 to L4. The average fat content was significantly elevated in patients with osteoporosis/osteopenia compared with controls, adjusted for age and body mass index (P < 0.05). CONCLUSION: In vivo MRS at high field strength provides reliable measurement of marrow adiposity with excellent reproducibility and can be a valuable tool for providing complementary information on bone quality and potentially also fracture risk.
PURPOSE: To determine the reproducibility of proton MR spectroscopy ((1) H-MRS) for assessing vertebral bone marrow adiposity at 3 Tesla (T); to evaluate variation of marrow adiposity at different vertebral levels; and to demonstrate the feasibility of using (1) H-MRS at 3T for evaluating marrow adiposity in subjects with low bone density. MATERIALS AND METHODS: Single voxel MRS was acquired at vertebral body L1 to L4 at 3T in 51 postmenopausal females including healthy controls (n = 13) and patients with osteoporosis/osteopenia (n = 38). Marrow fat contents were compared between vertebral levels and between groups using analysis of variance (ANOVA). Six subjects were scanned twice to evaluate technique reproducibility. RESULTS: The average coefficient of variation of vertebral marrow fat content quantification was 1.7%. Marrow fat content significantly increased from L1 to L4. The average fat content was significantly elevated in patients with osteoporosis/osteopenia compared with controls, adjusted for age and body mass index (P < 0.05). CONCLUSION: In vivo MRS at high field strength provides reliable measurement of marrow adiposity with excellent reproducibility and can be a valuable tool for providing complementary information on bone quality and potentially also fracture risk.
Authors: James F Griffith; David K W Yeung; Steven K K Chow; Jason Chi Shun Leung; Ping Chung Leung Journal: J Magn Reson Imaging Date: 2009-06 Impact factor: 4.813
Authors: James F Griffith; David K W Yeung; Gregory E Antonio; Francis K H Lee; Athena W L Hong; Samuel Y S Wong; Edith M C Lau; Ping Chung Leung Journal: Radiology Date: 2005-07-29 Impact factor: 11.105
Authors: David K W Yeung; James F Griffith; Gregory E Antonio; Francis K H Lee; Jean Woo; Ping C Leung Journal: J Magn Reson Imaging Date: 2005-08 Impact factor: 4.813
Authors: Gary P Liney; Clare P Bernard; David J Manton; Lindsay W Turnbull; Chris M Langton Journal: J Magn Reson Imaging Date: 2007-09 Impact factor: 4.813
Authors: C M Bastos; I M Araújo; M H Nogueira-Barbosa; C E G Salmon; F J A de Paula; L E A Troncon Journal: Osteoporos Int Date: 2017-04-12 Impact factor: 4.507
Authors: X Ojanen; R J H Borra; M Havu; S M Cheng; R Parkkola; P Nuutila; M Alen; S Cheng Journal: Osteoporos Int Date: 2013-08-14 Impact factor: 4.507
Authors: Dimitrios C Karampinos; Gerd Melkus; Thomas Baum; Jan S Bauer; Ernst J Rummeny; Roland Krug Journal: Magn Reson Med Date: 2014-03 Impact factor: 4.668
Authors: Patrick J Bolan; Luke Arentsen; Thanasak Sueblinvong; Yan Zhang; Steen Moeller; Jori S Carter; Levi S Downs; Rahel Ghebre; Douglas Yee; Jerry Froelich; Susanta Hui Journal: J Magn Reson Imaging Date: 2013-02-28 Impact factor: 4.813